Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
Condition(s):Anal CancerLast Updated:June 6, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Anal CancerLast Updated:June 6, 2018Completed
Condition(s):Anal CancerLast Updated:June 29, 2023Completed
Condition(s):Carcinoma of the Anal CanalLast Updated:April 2, 2019Unknown status
Condition(s):Anal Carcinoma; Anal CondylomaLast Updated:August 7, 2017Unknown status
Condition(s):Anal Dysplasia; Human Papilloma Virus; HIVLast Updated:August 22, 2016Withdrawn
Condition(s):Head and Neck Squamous Cell Carcinoma; Colorectal Cancer; Cutaneous Squamous Cell Carcinoma; Anal Squamous Cell Carcinoma; Cervical CancerLast Updated:May 16, 2023Completed
Condition(s):Anal Cancer; Locally Advanced Squamous Cell Carcinoma; Oligometastatic Disease; Circulating Tumor Cell; Human Papilloma VirusLast Updated:February 10, 2022Recruiting
Condition(s):Anal CancerLast Updated:March 15, 2017Withdrawn
Condition(s):Anal Canal Cancer; Anal Squamous Cell Carcinoma; Anal Cancer; Anal Canal Cancer Stage I; Anal Canal Cancer Stage II; Anal Canal Cancer Stage IIILast Updated:April 12, 2023Enrolling by invitation
Condition(s):Anal CancerLast Updated:October 10, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.